Brufsky AM - Search Results

1

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial.

Robidoux A, Tang G, Rastogi P, Geyer CE Jr, Azar CA, Atkins JN, Fehrenbacher L, Bear HD, Baez-Diaz L, Sarwar S, Margolese RG, Farrar WB, Brufsky AM, Shibata HR, Bandos H, Paik S, Costantino JP, Swain SM, Mamounas EP, Wolmark N. Robidoux A, et al. Among authors: brufsky am. Lancet Oncol. 2013 Nov;14(12):1183-92. doi: 10.1016/S1470-2045(13)70411-X. Epub 2013 Oct 4. Lancet Oncol. 2013. PMID: 24095300 Clinical Trial.

2

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer.

Low JA, Wedam SB, Lee JJ, Berman AW, Brufsky A, Yang SX, Poruchynsky MS, Steinberg SM, Mannan N, Fojo T, Swain SM. Low JA, et al. J Clin Oncol. 2005 Apr 20;23(12):2726-34. doi: 10.1200/JCO.2005.10.024. J Clin Oncol. 2005. PMID: 15837987 Clinical Trial.

3

Cognitive impairment associated with adjuvant therapy in breast cancer.

Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM. Bender CM, et al. Among authors: brufsky am. Psychooncology. 2006 May;15(5):422-30. doi: 10.1002/pon.964. Psychooncology. 2006. PMID: 16097037

4

Hormone receptor status does not affect the clinical benefit of trastuzumab therapy for patients with metastatic breast cancer.

Brufsky A, Lembersky B, Schiffman K, Lieberman G, Paton VE. Brufsky A, et al. Clin Breast Cancer. 2005 Aug;6(3):247-52. doi: 10.3816/CBC.2005.n.027. Clin Breast Cancer. 2005. PMID: 16137436

5

Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.

Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P, Cohen SM, Casillo FE, Berga SL. Bender CM, et al. Among authors: brufsky am. Menopause. 2007 Nov-Dec;14(6):995-8. doi: 10.1097/gme.0b013e318148b28b. Menopause. 2007. PMID: 17898668 Free PMC article.

6

What do perceived cognitive problems reflect?

Bender CM, Pacella ML, Sereika SM, Brufsky AM, Vogel VG, Rastogi P, Casillo FE, Richey SM, Ryan CM. Bender CM, et al. Among authors: brufsky am. J Support Oncol. 2008 May-Jun;6(5):238-42. J Support Oncol. 2008. PMID: 18551862 Free PMC article.

7

Trastuzumab-based therapy for patients with HER2-positive breast cancer: from early scientific development to foundation of care.

Brufsky A. Brufsky A. Am J Clin Oncol. 2010 Apr;33(2):186-95. doi: 10.1097/COC.0b013e318191bfb0. Am J Clin Oncol. 2010. PMID: 19675448 Review.

8

Adjuvant endocrine therapy for premenopausal women with breast cancer.

Puhalla S, Brufsky A, Davidson N. Puhalla S, et al. Breast. 2009 Oct;18 Suppl 3(0 3):S122-30. doi: 10.1016/S0960-9776(09)70286-3. Breast. 2009. PMID: 19914530 Free PMC article. Review.

9

Metastatic breast cancer or multiple myeloma? Camouflage by lytic lesions.

Hough B, Brufsky A, Lentzsch S. Hough B, et al. J Oncol. 2010;2010:509530. doi: 10.1155/2010/509530. Epub 2010 Mar 7. J Oncol. 2010. PMID: 20224644 Free PMC article.

10

The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer.

van Londen GJ, Perera S, Vujevich K, Rastogi P, Lembersky B, Brufsky A, Vogel V, Greenspan SL. van Londen GJ, et al. Breast Cancer Res Treat. 2011 Jan;125(2):441-6. doi: 10.1007/s10549-010-1223-2. Epub 2010 Nov 3. Breast Cancer Res Treat. 2011. PMID: 21046232 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters